Lauxera Capital Partners Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 12

Professionals

  • Investments
  • 33

  • Portfolio
  • 16

  • Exits
  • 1

Exits

Lauxera Capital Partners General Information

Company Description

Founded in 2020, Lauxera Capital Partners is a growth equity firm headquartered in Paris, France. The firm is an independent, international investment fund focused on growth companies in Healthtech. The firm's growth equity investments focus primarily on commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies. Led by entrepreneurial company builders and seasoned healthcare investors with experience across international markets, the firm empowers European Healthtech entrepreneurs to deliver the growth promised by their innovations.

Business Details

Website
www.lauxera.com
Year Founded
2020
Investor Status
Actively Seeking New Investments
Trade Association
French Venture Capital Association (AFIC)
Principles for Responsible Investment (PRI)
Primary Investor Type
Growth/Expansion
Other Investor Types
PE/Buyout
Corporate Office
  • 41 avenue de Friedland
  • 75008 Paris
  • France

Lauxera Capital Partners Investments (33)

Lauxera Capital Partners’s most recent investment was a with Angionautix. The deal was made on 28-Sep-2026 with as the lead partner.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Angionautix 28-Sep-2026 Distributors/Wholesale Generating Revenue
Bridge to Life 12-Aug-2026 Medical Supplies Generating Revenue
GenePlanet 30-Jul-2026 Laboratory Services (Healthcare) Generating Revenue
Natural Cycles 03-Jun-2026 Other Healthcare Technology Systems Generating Revenue
Simploud (Acquired by Matrix One) 06-Jan-2026 Buyout/LBO Enterprise Systems (Healthcare) Generating Revenue
You’re viewing 5 of 33 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lauxera Capital Partners Exits (1)

Lauxera Capital Partners has made one exit. Its exit was from OrganOx for on 29-Oct-2025, categorized as .

Company Name Exit Date Exit Type Exit Size
OrganOx 29-Oct-2025
To view Lauxera Capital Partners’s complete exits history, request access »

Lauxera Capital Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lauxera Capital Partners FAQs

  • What is Lauxera Capital Partners?

    Founded in 2020, Lauxera Capital Partners is a growth equity firm headquartered in Paris, France.

  • When was Lauxera Capital Partners founded?

    Lauxera Capital Partners was founded in 2020.

  • Where is Lauxera Capital Partners headquartered?

    Lauxera Capital Partners is headquartered in Paris, France.

  • What is Lauxera Capital Partners's total asset value?

    Lauxera Capital Partners has around in total assets under management.

  • How many investments has Lauxera Capital Partners made?

    Lauxera Capital Partners has made 33 investments.

  • What has Lauxera Capital Partners invested in?

    Lauxera Capital Partners has made numerous investments in companies like Angionautix, Bridge to Life, and GenePlanet within the Distributors/Wholesale, Medical Supplies, and Laboratory Services (Healthcare) industries.

  • What has Lauxera Capital Partners invested in recently?

    Lauxera Capital Partners's latest investment was on 28-Sep-2026 in Angionautix, a company within the Distributors/Wholesale industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process